Some participants reported initial challenges adapting to dramatically reduced appetite, requiring counseling to ensure adequate nutritional intake
However, GLP-1 therapy can unmask or worsen pre-existing androgenic alopecia through hormonal changes associated with fat loss, particularly in women over 40
Like other GLP-1 drugs, Foundayo can cause side effects such as nausea, constipation, diarrhea, vomiting, abdominal pain, and headache, according to the FDA
In a healthcare environment already defined by rising costs, the GLP-1 surge presents a critical challenge that requires a strategic, forward-thinking approach to plan design and cost containment
Drug dosing isn't guesswork
Despite those steps, it is unlikely Blue Cross will end 2026 in the black